THE PRESENT APPLICATION RELATES TO A SOLID UNIT DOSAGE FORM FOR ORAL ADMINISTRATION IN FORM OF A TABLET HAVING A CORE AND AN OUTER COATING, WHEREIN - THE CORE OF SAID TABLET COMPRISES A THERAPEUTICALLY EFFECTIVE AMOUNT OF ALISKIREN, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND - THE OUTER COATING IS IN FORM OF A FILM-COAT WHICH HAS TASTE MASKING PROPERTIES AND/OR A CONTROLLED RELEASE FUNCTIONALITY. PREFERABLY, THE CORE TABLET IS PART OF A MULTIPARTICULATE SYSTEM, PARTICULARLY A MINITABLET. THE SOLID ORAL DOSAGE FORM IS PARTICULARLY SUITABLE FOR PEDIATRIC USE. THE MOST ILLUSTRATIVE DRAWING ACCOMPANYING THE ABSTRACT: FIG. 1
